University Of Chicago
Clinical trials sponsored by University Of Chicago, explained in plain language.
-
Immune drug shows promise against rare cancer
Disease control CompletedThis study tested the drug pembrolizumab in 65 people with malignant mesothelioma, a rare cancer of the lining around the lungs or abdomen. The drug works by helping the immune system attack cancer cells. The goal was to see if it could control the disease in patients whose cance…
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated May 17, 2026 08:25 UTC
-
New drug cocktail shows promise for Tough-to-Treat myeloma
Disease control CompletedThis early-phase study tested a combination of three drugs (selinexor, carfilzomib, and dexamethasone) in 52 adults with multiple myeloma that had returned or stopped responding to prior treatments. The main goal was to find the safest dose and identify side effects. Researchers …
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated May 17, 2026 08:25 UTC
-
Could a diabetes pill help heart failure patients with mechanical hearts?
Disease control CompletedThis study looked at whether a type of diabetes medicine called SGLT2 inhibitors can help people with severe heart failure who also have a mechanical heart pump (LVAD). Researchers measured changes in heart size, weight, and kidney function over six months in 32 adults. The goal …
Phase: PHASE4 • Sponsor: University of Chicago • Aim: Disease control
Last updated May 17, 2026 08:24 UTC
-
New hope for aggressive lymphoma: drug combo shows promise in early trial
Disease control CompletedThis study tested a combination of the drug lenalidomide with standard chemotherapy (called DA-EPOCH-R) in 55 people with a fast-growing type of B-cell lymphoma linked to the MYC gene. The goal was to find the safest dose and see if the combo helps keep the cancer from growing or…
Phase: PHASE1, PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated May 17, 2026 08:20 UTC
-
New drug cocktail shows promise for Hard-to-Treat myeloma
Disease control CompletedThis study tested a combination of three drugs (pomalidomide, dexamethasone, and carfilzomib) in 25 people whose multiple myeloma had returned or stopped responding to prior treatments. The goal was to find the safest dose and see how well the drugs worked together. Results helpe…
Phase: PHASE1, PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Breakthrough drug combo may unlock kidney transplants for 'impossible' patients
Disease control CompletedThis study tested a new combination of two drugs (belatacept and a proteasome inhibitor) in 5 highly sensitized kidney transplant candidates. The goal was to lower their strong immune antibodies so they could find a compatible donor. The approach aims to safely increase the chanc…
Phase: PHASE1, PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Could a diabetes drug boost chemo for ovarian cancer?
Disease control CompletedThis study tested whether adding metformin (a common diabetes drug) to standard chemotherapy could help people with advanced ovarian, fallopian tube, or primary peritoneal cancer. About 111 participants received either metformin or a placebo alongside chemo, then continued metfor…
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Community support from home helps seniors with diabetes stay on track
Disease control CompletedThis study tested whether remote support—like phone check-ins and connecting people to community resources—could help older adults with type 2 diabetes better manage their condition. Over 500 participants received personalized goal-setting and care coordination for 12 months. The…
Phase: NA • Sponsor: University of Chicago • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Heart drug metoprolol may shield patients from Post-Surgery heart injury
Disease control CompletedThis study tested whether giving metoprolol, an FDA-approved heart medication, right after surgery and during hospital recovery can reduce heart damage in people with coronary artery disease. Researchers monitored daily blood tests for signs of heart injury in 72 older adults. Th…
Phase: PHASE3 • Sponsor: University of Chicago • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New combo therapy shows promise for Tough-to-Treat prostate cancer
Disease control CompletedThis early-stage study tested a new drug combination for men with advanced prostate cancer that no longer responds to standard hormone therapy. The trial included 42 participants and aimed to see if adding relacorilant to enzalutamide is safe and can help control the disease. Res…
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
Catching more Zzz's may cut diabetes risk, small study suggests
Disease control CompletedThis study looked at whether helping people sleep longer or on a more regular schedule could improve their metabolic health and lower their risk for diabetes and obesity. Researchers studied 18 overweight adults who typically slept less than 7 hours a night. Over 24 days, they tr…
Phase: NA • Sponsor: University of Chicago • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
New combo aims to wipe out remaining myeloma after transplant
Disease control CompletedThis study looked at 42 people with multiple myeloma that remained after a stem cell transplant. It compared taking lenalidomide alone versus adding two other drugs (ixazomib and dexamethasone) to see if the combo could better clear the leftover cancer. The goal was to find a mor…
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated May 11, 2026 20:48 UTC
-
New drug cocktail shows promise in taming early-stage bone marrow cancer
Disease control CompletedThis study tested a three-drug combination (carfilzomib, lenalidomide, and dexamethasone) given before and after a stem cell transplant in 76 people newly diagnosed with multiple myeloma, a type of blood cancer. The goal was to see how well the treatment could control the disease…
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated May 11, 2026 20:38 UTC
-
Smartphone app aims to tame high blood pressure in african americans
Disease control CompletedThis study tested a smartphone app called USeeBP to help African American adults with poorly controlled high blood pressure. 31 participants used the app alongside their usual care. The goal was to see if the app could help lower blood pressure readings.
Phase: NA • Sponsor: University of Chicago • Aim: Disease control
Last updated May 01, 2026 15:59 UTC
-
Powerful cocktail shows promise against bone marrow cancer
Disease control CompletedThis study tested a combination of four drugs (elotuzumab, carfilzomib, lenalidomide, and dexamethasone) in 46 people newly diagnosed with multiple myeloma, a blood cancer. The goal was to see how many patients achieved a very deep remission (stringent complete response or minima…
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Apr 29, 2026 15:03 UTC
-
Vitamin d put to the test against COVID-19
Prevention CompletedThis study tested whether taking a moderate dose of vitamin D (4,000 IU daily) could lower the chance of getting COVID-19 compared to a low dose (400 IU daily). Over 2,000 adults from the Chicago area and other US communities took part. Participants reported any COVID-19 infectio…
Phase: NA • Sponsor: University of Chicago • Aim: Prevention
Last updated May 17, 2026 08:22 UTC
-
Can vitamin d stop COVID? chicago study tests high doses
Prevention CompletedThis study looked at whether taking moderate (4,000 IU) or high (10,000 IU) doses of vitamin D daily could lower the risk of getting COVID-19 compared to a low dose (400 IU). About 1,475 adults from the Chicago area took part for 9 months. Researchers tracked who got a confirmed …
Phase: NA • Sponsor: University of Chicago • Aim: Prevention
Last updated May 17, 2026 08:19 UTC
-
Less pressure, less pain? new study tests simple change in robotic surgery
Symptom relief CompletedThis study looked at 70 women having robotic surgery for pelvic organ prolapse. It compared standard gas pressure (15 mmHg) to a slightly lower pressure (12 mmHg) during the operation. The goal was to see if lower pressure leads to less pain right after surgery, without making it…
Phase: NA • Sponsor: University of Chicago • Aim: Symptom relief
Last updated May 17, 2026 08:33 UTC
-
Could a new pill ease borderline personality disorder?
Symptom relief CompletedThis study tested whether the drug Caplyta (lumateperone) can reduce symptoms of borderline personality disorder (BPD). Sixty adults with BPD were randomly assigned to take either Caplyta or a placebo pill every day for 8 weeks. Researchers measured changes in BPD symptoms and ag…
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Symptom relief
Last updated May 17, 2026 08:32 UTC
-
Body fat to the rescue: can your own tissue reverse radiation scars?
Symptom relief CompletedThis small study tested whether taking fat from one part of the body and moving it to a breast that was damaged by radiation could improve skin health. Ten women who had radiation for breast cancer took part. The goal was to see if this fat transfer could make the skin softer and…
Sponsor: University of Chicago • Aim: Symptom relief
Last updated May 17, 2026 08:32 UTC
-
Magic mushroom compound shows promise for Tough-to-Treat depression and BPD
Symptom relief CompletedThis small study tested a single dose of psilocybin, the active ingredient in magic mushrooms, in 9 adults with both major depression and borderline personality disorder. Researchers measured changes in depression and BPD symptoms over time to see if the treatment was safe and he…
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Symptom relief
Last updated May 17, 2026 08:32 UTC
-
Can a CBD drug ease OCD and tics? small study hints at possibility
Symptom relief CompletedThis early study tested the drug Epidiolex (a form of cannabidiol) in 4 adults with obsessive-compulsive disorder, hair-pulling, Tourette syndrome, or hoarding. Participants took the drug for two weeks, and researchers tracked changes in symptoms using standard rating scales. The…
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Symptom relief
Last updated May 17, 2026 08:23 UTC
-
Fiber fix? Grocery-Store supplement may ease peanut allergy treatment in kids
Symptom relief CompletedThis pilot study tested whether adding a common fiber supplement (prebiotic) to peanut oral immunotherapy helps children with peanut allergy tolerate more peanut protein with fewer stomach side effects. Twenty children aged 4 to 17 participated. The goal was to see if the fiber m…
Phase: PHASE1, PHASE2 • Sponsor: University of Chicago • Aim: Symptom relief
Last updated May 14, 2026 12:04 UTC
-
Can an AI and VR app ease anxiety in IBD patients?
Symptom relief CompletedThis small study tested whether a digital wellness app using artificial intelligence and virtual reality could safely provide mental health support to adults with inflammatory bowel disease who also have mild anxiety or depression. Twenty-two participants used the app during a si…
Phase: NA • Sponsor: University of Chicago • Aim: Symptom relief
Last updated May 13, 2026 16:02 UTC
-
Cooling pillow pad shows promise for better sleep in overweight adults
Symptom relief CompletedThis study tested a special cooling pillow pad called Moona to see if it could help African American adults with overweight or obesity sleep better. 18 people took part. The goal was to measure changes in sleep quality and related health markers like blood sugar control. The stud…
Phase: NA • Sponsor: University of Chicago • Aim: Symptom relief
Last updated Apr 26, 2026 20:03 UTC
-
Fat cell secrets revealed: Surgery's impact on metabolism
Knowledge-focused CompletedThis study looked at how daily rhythms affect fat cell genes and insulin response in 28 women with severe obesity scheduled for bariatric surgery. Researchers measured changes in fat cell insulin sensitivity before and 12 weeks after surgery. The goal was to understand the body's…
Phase: NA • Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated May 17, 2026 08:32 UTC
-
Video training may cut infection risk for home nutrition patients
Knowledge-focused CompletedThis study tested whether an educational video on safe catheter care could reduce bloodstream infections in adults starting home parenteral nutrition for intestinal failure. 25 first-time users watched the video and were monitored for infection events. The goal was to see if simp…
Phase: NA • Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated May 17, 2026 08:31 UTC
-
Remote genetic counseling helps cancer survivors understand their risks
Knowledge-focused CompletedThis study looked at whether offering genetic counseling and testing remotely can help childhood cancer survivors get the genetic services they need. About 391 survivors took part, and the goal was to see if more people would complete genetic testing or counseling with this appro…
Phase: NA • Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated May 17, 2026 08:31 UTC
-
Sleep program aims to boost stroke recovery in rehab
Knowledge-focused CompletedThis study tested a program to improve sleep for 400 stroke patients in rehabilitation. The program trained nurses to reduce nighttime disruptions and screened patients for sleep apnea. The goal was to see if better sleep could improve recovery and daily function.
Phase: NA • Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated May 17, 2026 08:24 UTC
-
Can a simple pain scale help dementia patients in the ER?
Knowledge-focused CompletedThis study tested whether a special pain scale called PAINAD helps emergency room staff better assess and treat pain in people with dementia. Over 700 older adults with dementia and hip pain took part. The goal was to see if using this tool leads to quicker and more accurate pain…
Phase: NA • Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated May 17, 2026 08:23 UTC
-
Could a simple surgery replace years of hormone shots for prostate cancer?
Knowledge-focused CompletedThis study looked at whether teaching men with advanced prostate cancer about orchiectomy (surgery to remove the testicles) would make them more likely to choose it over lifelong hormone therapy. 101 men who were already on hormone therapy for at least a year took part. The goal …
Phase: NA • Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated May 17, 2026 08:23 UTC
-
Can removing certain immune cells improve stem cell transplants for myeloma?
Knowledge-focused CompletedThis early-phase study looked at whether it is safe and possible to remove a specific type of immune cell (regulatory T cells) in 30 people with multiple myeloma who were getting a stem cell transplant using their own cells. The goal was to see if this removal could be done effec…
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated May 17, 2026 08:21 UTC
-
New strategies aim to shield right heart after LVAD implant
Knowledge-focused CompletedThis study looked at ways to protect the right side of the heart after patients receive a mechanical pump (LVAD) for heart failure. Twenty adults who had LVAD surgery were monitored closely for several days. The goal was to find better methods to prevent right heart problems afte…
Phase: NA • Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC
-
Ultrasound peek at breathing muscles could Fine-Tune ventilator care
Knowledge-focused CompletedThis study observed 66 ICU patients on mechanical ventilators to see if ultrasound measurements of the diaphragm differ between two breathing modes. Researchers measured diaphragm thickness during controlled and spontaneous breaths, and also during a sedation pause. The goal was …
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC
-
Global registry tracks new heart pacing technique
Knowledge-focused CompletedThis study collected information from 383 people with slow heartbeats or heart failure who received a special type of pacemaker called conduction system pacing. The goal was to see how well this pacing method works in everyday medical practice around the world. Researchers tracke…
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated May 14, 2026 12:03 UTC